United Therapeutics (NASDAQ:UTHR) CEO Martine Rothblatt Sells 9,500 Shares
United Therapeutics Corporation (NASDAQ:UTHR – Get Free Report) CEO Martine Rothblatt sold 9,500 shares of the stock in a transaction dated Wednesday, June 3rd. The stock was sold at an average price of $547.61, for a total value of $5,202,295.00. Following the sale, the chief executive officer directly owned 40,513 shares in the company, valued […]
4 Jun 21:09 · The Markets Daily